Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

ADMA Q3 2016 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

Q3 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$1M40.9% margin

Operating Income

-$4M-127.2% margin

Net Income

-$4M-147.4% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+29.3%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$262,963

Balance Sheet

Total Assets

$27M

Total Liabilities

$28M

Stockholders' Equity

-$152,140

Cash & Equivalents

$8M

Revenue Segments

Plasma Collection Center Member

$3M99%

Corporate Member

$35,7081%

← FY 2016 All Quarters Q4 2016 →